Loading company details...
Beta
Latest Form 4 (Aug 4, 2026): Richard E. Uihlein (Director): Exercise/Conversion of 31,825,235 shares, $95.48M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 4, 2026 | Richard E. Uihlein | Exercise/Conversion | 31,825,235 | $95.48M |
| Jul 16, 2026 | Khurram Jamil, Chief Medical Officer | Exercise/Conversion | 16,250 | $49.4K |
| Jun 30, 2026 | Harold H. Shlevin | Exercise/Conversion | 7,732 | $9.5K |
| Jun 30, 2026 | Khurram Jamil, Chief Medical Officer | Exercise/Conversion | 2,037 | $4.5K |
| Jun 25, 2026 | Khurram Jamil, Chief Medical Officer | Exercise/Conversion | 7,557 | $9.3K |
| May 28, 2026 | Khurram Jamil, Chief Medical Officer | Exercise/Conversion | 568 | $698.64 |
| Mar 17, 2026 | Henry Brem | Grant/Award | 60,000 | n/a |
| Feb 9, 2026 | Kary Eldred | Purchase | 300 | $810.00 |
| Jan 21, 2026 | Benjamin Carson Sr. | Grant/Award | 60,000 | n/a |
| Jan 21, 2026 | Richard A. Zordani Jr. | Grant/Award | 60,000 | n/a |